Bio Protocol vs iExec RLC — how do they compare? Bio Protocol trades at Rp429 (market cap Rp972,61M, Rp151,33M 24h volume), while iExec RLC trades at Rp4,742 (market cap Rp410,86M, Rp19,82M 24h volume). The key difference: Bio Protocol is far larger — about 2.4× iExec RLC's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 87M / 87M RLC (100%) for iExec RLC. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and iExec RLC for 35 Days on average.
| BIO | RLC | |
|---|---|---|
Market Cap | Rp972,61M | Rp410,86M |
Volume (24h) | Rp151,33M | Rp19,82M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 87M / 87M RLC (100%) |
Typical Hold Time | 18 Days | 35 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
iExec RLC is trading at Rp4,743 with a market cap of Rp412.34M, showing bearish technical signals with moving averages indicating strong selling pressure. The token is fully circulated with 87 million tokens in supply and average hold time of 35 days. Current price sits between support at Rp4,656 and resistance at Rp4,780, with oscillators showing neutral momentum.
Overall outlook remains cautious with bearish technical dominance. Key opportunity lies in potential bounce from support levels, while major risks include limited liquidity and crypto market volatility. Investors should monitor for protocol updates and exchange volume changes.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →iExec (RLC) is the leading provider of blockchain-based decentralized computing. Blockchain is utilized to organize a market network where people can monetize their computing power as well as applications and even datasets. iExec can support applications in fields such as big data, healthcare, AI, rendering and fintech. IExec was founded on Oct. 16, 2016, with the goal to reinvent cloud computing through the creation of a new cloud computing paradigm.
Read more on RLC →